MAPT and Alzheimer disease: While frontotemporal lobar degeneration with tau-immunoreactive lesions (i.e. tauopathies) also have hyperphosphorylated tau in the brain, AD has the greatest lesional burden, which correlates with CSF p-tau levels (30).